Neuroendocrine expression in metastaticprostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression
- 1 April 2000
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 31 (4), 406-414
- https://doi.org/10.1053/hp.2000.7295
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Pre- and postnatal testosterone administration induces proliferative epithelial lesions with neuroendocrine differentiation in the dorsal lobe of the rat prostateThe Prostate, 1999
- Kinetics of Neuroendocrine Differentiation in an Androgen-Dependent Human Prostate Xenograft ModelThe American Journal of Pathology, 1999
- Simultaneous detection of DNA fragmentation (apoptosis), cell proliferation (MIB-1), and phenotype markers in routinely processed tissue sections.Virchows Archiv, 1999
- A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cellsProceedings of the National Academy of Sciences, 1998
- FOCAL NEUROENDOCRINE DIFFERENTIATION LACKS PROGNOSTIC SIGNIFICANCE IN PROSTATE CORE NEEDLE BIOPSIESJournal of Urology, 1998
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Neuroendocrine differentiation and hormone-refractory prostate cancerThe Prostate, 1996
- The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long‐term follow‐up study with patients treated by radical prostatectomyInternational Journal of Cancer, 1995
- Immunohistochemical detection of oncogene proteins and neuroendocrine differentiation in different stages of prostate cancerPathology, 1995
- Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinomaCancer, 1993